Cost of Drugs: List Price versus Net Price

In a recent report by PhRMA, found that over 50% of out-of-pocket spending by commercially insured patients is based on the list price of a medicine, rather than the negotiated, lower net price. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply